**Author details**

Ozan Unlu1 , Zaid I. Almarzooq2 , Diala Steitieh1 , Matthew Brandorff1 and Parmanand Singh3 \*

1 Department of Medicine, Weill Cornell Medicine, New York, NY, USA

2 Department of Cardiology, Brigham and Women's Hospital, Boston, MA, USA

3 Department of Cardiology, Weill Cornell Medicine, New York, NY, USA

\*Address all correspondence to: pas9062@med.cornell.edu

© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**15**

*Diagnosis and Surveillance of Aortic Root Dilation DOI: http://dx.doi.org/10.5772/intechopen.86329*

The Canadian Journal of Cardiology.

[8] Sakai LY et al. Purification and partial characterization of fibrillin, a cysteine-rich structural component of connective tissue microfibrils. The Journal of Biological Chemistry.

1991;**266**(22):14763-14770

2010;**31**(12):E1915-E1927

nih.gov/books/NBK1335/

2016;**26**(5):423-428

2004;**36**(8):790-792

2005;**37**(3):275-281

2004;**36**(8):855-860

[12] Pyeritz RE. Recent progress in understanding the natural and clinical histories of the Marfan syndrome. Trends in Cardiovascular Medicine.

[13] Akhurst RJ. TGF beta signaling in health and disease. Nature Genetics.

[14] Loeys BL et al. A syndrome of altered cardiovascular, craniofacial,

development caused by mutations in TGFBR1 or TGFBR2. Nature Genetics.

[15] Mizuguchi T et al. Heterozygous TGFBR2 mutations in Marfan syndrome. Nature Genetics.

neurocognitive and skeletal

[9] Judge DP, Dietz HC. Marfan's syndrome. Lancet. 2005;**366**(9501):

[10] Hilhorst-Hofstee Y et al. The clinical spectrum of missense mutations of the first aspartic acid of cbEGF-like domains in fibrillin-1 including a recessive family. Human Mutation.

[11] Dietz H. Marfan syndrome. 2001. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle, WA: University of Washington, Seattle; 1993-2018. Available from: https://www.ncbi.nlm.

2016;**32**(1):66-77

1965-1976

[1] Boyer JK, Gutierrez F, Braverman AC. Approach to the dilated aortic root. Current Opinion in Cardiology.

[2] Roman MJ et al. Two-dimensional

[3] Kim JB et al. Risk of aortic dissection in the moderately dilated ascending aorta. Journal of the American College of Cardiology. 2016;**68**(11):1209-1219

[4] Landenhed M et al. Risk profiles for aortic dissection and ruptured or surgically treated aneurysms: A prospective cohort study. Journal of the American Heart Association.

[5] Nataf P, Lansac E. Dilation of the thoracic aorta: Medical and surgical management. Heart.

[6] Douglas PS et al. ACCF/ASE/AHA/ ASNC/HFSA/HRS/SCAI/SCCM/SCCT/ SCMR 2011 Appropriate Use Criteria for Echocardiography. A report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Society of Echocardiography, American Heart Association, American Society of

Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Critical Care Medicine, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance American College of Chest Physicians. Journal of the American Society of Echocardiography. 2011;**24**(3):229-267

[7] Singh MN, Lacro RV. Recent clinical drug trials evidence in Marfan syndrome and clinical implications.

echocardiographic aortic root dimensions in normal children and adults. The American Journal of Cardiology. 1989;**64**(8):507-512

**References**

2004;**19**(6):563-569

2015;**4**(1):e001513

2006;**92**(9):1345-1352

*Diagnosis and Surveillance of Aortic Root Dilation DOI: http://dx.doi.org/10.5772/intechopen.86329*
